OnKure and CU Cancer Center announce first patient enrolled in clinical trial of OKI-179
OnKure Announces FDA IND Regulatory Clearance to Start Phase 1 Trials for OKI-179
OnKure Close $7M Series A Financing to Support Development of Epigenetics Drug
